Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
India
/
Materials
/
Jubilant Ingrevia
JUBLINGREA
Jubilant Ingrevia
Regulatory Tensions And China+1 Shifts Will Test Recovery Prospects
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 4 Analysts
Published
25 Jul 25
Updated
16 Aug 25
0
Set Fair Value
0
votes
Share
AnalystLowTarget
's Fair Value
₹743.00
5.6% undervalued
intrinsic discount
16 Aug
₹701.70
Loading
1Y
9.1%
7D
0.1%
Author's Valuation
₹743.0
5.6% undervalued
intrinsic discount
AnalystLowTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystLowTarget Fair Value
₹743.0
5.6% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
-4m
69b
2020
2021
2022
2023
2024
2025
2026
2027
2028
Revenue ₹69.3b
Earnings ₹6.5b
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
17.40%
Chemicals revenue growth rate
0.36%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
13.65%
Calculation
₹6.46b
Earnings '28
x
26.49x
PE Ratio '28
=
₹171.23b
Market Cap '28
₹171.23b
Market Cap '28
/
157.68m
No. shares '28
=
₹1.09k
Share Price '28
₹1.09k
Share Price '28
Discounted to 2025 @ 13.65% p.a.
=
₹739.79
Fair Value '25
